BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35112184)

  • 1. Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification.
    Arase H; Yamada S; Torisu K; Tokumoto M; Taniguchi M; Tsuruya K; Nakano T; Kitazono T
    Calcif Tissue Int; 2022 Jun; 110(6):685-697. PubMed ID: 35112184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic phosphate exporter heterozygosity in mice leads to brain vascular calcification, microangiopathy, and microgliosis.
    Maheshwari U; Mateos JM; Weber-Stadlbauer U; Ni R; Tamatey V; Sridhar S; Restrepo A; de Jong PA; Huang SF; Schaffenrath J; Stifter SA; Szeri F; Greter M; Koek HL; Keller A
    Brain Pathol; 2023 Nov; 33(6):e13189. PubMed ID: 37505935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
    Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
    Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease.
    Dong QQ; Tu YC; Gao P; Liao QQ; Zhou P; Zhang H; Shu HP; Sun LL; Feng L; Yao LJ
    Theranostics; 2024; 14(2):861-878. PubMed ID: 38169564
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
    Ishiwata R; Morimoto Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166323. PubMed ID: 34921974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKAP4 contributes to the progression of vascular calcification (VC) in chronic kidney disease (CKD) by modulating YAP phosphorylation and MMP2 expression.
    Shi Y; Jin X; Yang M; Jia J; Yao H; Yuan W; Wang K; Rong S
    Cell Signal; 2022 May; 93():110270. PubMed ID: 35108641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a.
    Caus M; Alonso-Montes C; Fernandez-Martin JL; Marti-Antonio M; Bozic M; Valdivielso JM
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1533-1548. PubMed ID: 37381989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.
    Crouthamel MH; Lau WL; Leaf EM; Chavkin NW; Wallingford MC; Peterson DF; Li X; Liu Y; Chin MT; Levi M; Giachelli CM
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2625-32. PubMed ID: 23968976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis.
    López-Sánchez U; Tury S; Nicolas G; Wilson MS; Jurici S; Ayrignac X; Courgnaud V; Saiardi A; Sitbon M; Battini JL
    J Biol Chem; 2020 Jul; 295(28):9366-9378. PubMed ID: 32393577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
    Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.
    Li KL; Chen J; Li ZH; Zhao L; He YN
    Cardiovasc J Afr; 2012 Jul; 23(6):e1-9. PubMed ID: 22143460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
    Platko K; Lebeau PF; Gyulay G; Lhoták Š; MacDonald ME; Pacher G; Hyun Byun J; Boivin FJ; Igdoura SA; Cutz JC; Bridgewater D; Ingram AJ; Krepinsky JC; Austin RC
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1664-1679. PubMed ID: 32434409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.
    Chao CT; Lin SH
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.
    Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM
    Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Extracellular Vesicle-Propagated microRNA Signature as a Vascular Calcification Factor in Chronic Kidney Disease.
    Koide T; Mandai S; Kitaoka R; Matsuki H; Chiga M; Yamamoto K; Yoshioka K; Yagi Y; Suzuki S; Fujiki T; Ando F; Mori T; Susa K; Iimori S; Naito S; Sohara E; Rai T; Yokota T; Uchida S
    Circ Res; 2023 Feb; 132(4):415-431. PubMed ID: 36700539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.
    Rodenbeck SD; Zarse CA; McKenney-Drake ML; Bruning RS; Sturek M; Chen NX; Moe SM
    Nephrol Dial Transplant; 2017 Mar; 32(3):450-458. PubMed ID: 27510531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion.
    Bouabdallah J; Zibara K; Issa H; Lenglet G; Kchour G; Caus T; Six I; Choukroun G; Kamel S; Bennis Y
    Nephrol Dial Transplant; 2019 Jul; 34(7):1125-1134. PubMed ID: 30481303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease.
    Jin D; Lin L; Xie Y; Jia M; Qiu H; Xun K
    FASEB J; 2022 Jan; 36(1):e22098. PubMed ID: 34918390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
    Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
    Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.